FDA Drug Recalls

Recalls / Class II

Class IID-0566-2020

Product

fentaNYL 1000 mcg/20 mL (50 mcg/mL) 20 mL in 20 mL Syringe Preservative Free, Rx, QuVA Pharma 1075 West Park One Drive, Suite 100 Sugar Land, TX 77478 NDC 70092-1415-47

Affected lot / code info
Lots: 10030359 Exp. 11/21/2019, 10030549 Exp. 11/28/2019, 10031169 Exp. 12/8/2019, 10031491 Exp. 12/16/2019, 10031879 Exp. 12/24/2019, 10032317 Exp. 12/31/2019, 10032265 Exp. 12/30/2019

Why it was recalled

Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

Recalling firm

Firm
QuVa Pharma, Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
1075 W Park One Dr Ste 100, Sugar Land, Texas 77478-2576

Distribution

Distribution pattern
Nationwide.

Timeline

Recall initiated
2019-11-12
FDA classified
2019-12-03
Posted by FDA
2019-12-11
Terminated
2020-06-05
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0566-2020. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.